E
Applied DNA Sciences, Inc.
APDN
$3.75
-$0.34-8.31%
E
Sell
3/6/2024Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 3/6/2024 due to a decline in the volatility index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 3/6/2024 due to a decline in the volatility index.
D
Sell
2/20/2024Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 2/20/2024 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.2647 to -$0.09, total revenue increased 14.3% from $779.7 to $891.2, and EBIT increased 9.15% from -$4.17M to -$3.79M.
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 2/20/2024 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.2647 to -$0.09, total revenue increased 14.3% from $779.7 to $891.2, and EBIT increased 9.15% from -$4.17M to -$3.79M.
E
Sell
1/25/2024Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 1/25/2024 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.07 to 0.1, and the quick ratio declined from 3.96 to 2.6.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 1/25/2024 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.07 to 0.1, and the quick ratio declined from 3.96 to 2.6.
D
Sell
8/4/2023Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 8/4/2023 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.2977 to $0.0456, and operating cash flow increased 109% from -$2.38M to $214.4.
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 8/4/2023 due to a noticeable increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.2977 to $0.0456, and operating cash flow increased 109% from -$2.38M to $214.4.
E
Sell
3/14/2023Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell
3/7/2023Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 3/7/2023 due to a decline in the volatility index and total return index.
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 3/7/2023 due to a decline in the volatility index and total return index.
D
Sell
2/10/2023Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 2/10/2023 due to an increase in the total return index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 2/10/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index and valuation index. Operating cash flow declined 85.75% from -$1.75M to -$3.26M, EBIT declined 53.98% from -$2.84M to -$4.37M, and total revenue declined 17.16% from $4.3M to $3.56M.
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 2/8/2023 due to a large decline in the growth index and valuation index. Operating cash flow declined 85.75% from -$1.75M to -$3.26M, EBIT declined 53.98% from -$2.84M to -$4.37M, and total revenue declined 17.16% from $4.3M to $3.56M.
D
Sell
5/16/2022Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 5/16/2022 due to a large increase in the growth index. Operating cash flow increased 92.93% from -$3.7M to -$261.9, earnings per share increased from -$0.6307 to -$0.2312, and EBIT increased 56.96% from -$4.63M to -$1.99M.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 5/16/2022 due to a large increase in the growth index. Operating cash flow increased 92.93% from -$3.7M to -$261.9, earnings per share increased from -$0.6307 to -$0.2312, and EBIT increased 56.96% from -$4.63M to -$1.99M.
E
Sell
5/13/2022Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index and total return index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index and total return index.
D
Sell
4/26/2022Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 4/26/2022 due to an increase in the volatility index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 4/26/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index.
D
Sell
4/19/2022Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 4/19/2022 due to an increase in the volatility index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 4/19/2022 due to an increase in the volatility index.
D
Sell
3/30/2022Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 3/30/2022 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 27.44% from -$3.64M to -$4.63M, and earnings per share declined from -$0.6019 to -$0.6307.
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 3/30/2022 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 27.44% from -$3.64M to -$4.63M, and earnings per share declined from -$0.6019 to -$0.6307.
D
Sell
12/13/2021Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 12/13/2021 due to a substantial increase in the growth index and volatility index. Total revenue increased 78.77% from $1.7M to $3.04M.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 12/13/2021 due to a substantial increase in the growth index and volatility index. Total revenue increased 78.77% from $1.7M to $3.04M.
D
Sell
11/26/2021Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 11/26/2021 due to a decline in the total return index and volatility index.
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 11/26/2021 due to a decline in the total return index and volatility index.
D
Sell
11/9/2021Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 11/09/2021.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the total return index and solvency index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the total return index and solvency index.
D
Sell
1/28/2021Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 1/28/2021 due to a noticeable increase in the total return index and volatility index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 1/28/2021 due to a noticeable increase in the total return index and volatility index.
D
Sell
12/18/2020Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 12/18/2020 due to a large decline in the growth index and valuation index. Total revenue declined 27.23% from $431.5 to $314, EBIT declined 27.09% from -$3.19M to -$4.05M, and earnings per share declined from -$0.7185 to -$0.801.
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 12/18/2020 due to a large decline in the growth index and valuation index. Total revenue declined 27.23% from $431.5 to $314, EBIT declined 27.09% from -$3.19M to -$4.05M, and earnings per share declined from -$0.7185 to -$0.801.
D
Sell
5/1/2020Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index, total return index and volatility index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index, total return index and volatility index.
D
Sell
2/7/2020Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 2/7/2020 due to a decline in the growth index, total return index and volatility index. Total revenue declined 62.13% from $1.67M to $633.5, operating cash flow declined 53.74% from -$1.78M to -$2.73M, and EBIT declined 40.11% from -$1.86M to -$2.61M.
Applied DNA Sciences, Inc. (APDN) was downgraded to D- from D on 2/7/2020 due to a decline in the growth index, total return index and volatility index. Total revenue declined 62.13% from $1.67M to $633.5, operating cash flow declined 53.74% from -$1.78M to -$2.73M, and EBIT declined 40.11% from -$1.86M to -$2.61M.
D
Sell
8/19/2019Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 8/19/2019 due to a substantial increase in the growth index. Total revenue increased 163.78% from $778.5 to $2.05M, earnings per share increased from -$0.0804 to -$0.0388, and EBIT increased 45.62% from -$2.63M to -$1.43M.
Applied DNA Sciences, Inc. (APDN) was upgraded to D from E+ on 8/19/2019 due to a substantial increase in the growth index. Total revenue increased 163.78% from $778.5 to $2.05M, earnings per share increased from -$0.0804 to -$0.0388, and EBIT increased 45.62% from -$2.63M to -$1.43M.
E
Sell
8/14/2019Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 8/14/2019 due to a decline in the total return index and volatility index.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 8/14/2019 due to a decline in the total return index and volatility index.
D
Sell
5/15/2019Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 5/15/2019 due to an increase in the valuation index and solvency index. Debt to equity declined from 2.8 to -2.99.
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 5/15/2019 due to an increase in the valuation index and solvency index. Debt to equity declined from 2.8 to -2.99.
E
Sell
12/19/2018Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 12/19/2018 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 122.3% from -$1.13M to -$2.51M, earnings per share declined from -$0.0959 to -$0.1189, and EBIT declined 20.9% from -$2.87M to -$3.47M.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 12/19/2018 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 122.3% from -$1.13M to -$2.51M, earnings per share declined from -$0.0959 to -$0.1189, and EBIT declined 20.9% from -$2.87M to -$3.47M.
D
Sell
9/1/2017Upgraded
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 9/1/2017 due to an increase in the total return index, volatility index and growth index.
Applied DNA Sciences, Inc. (APDN) was upgraded to D- from E+ on 9/1/2017 due to an increase in the total return index, volatility index and growth index.
E
Sell
8/11/2017Downgrade
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 8/11/2017 due to a decline in the total return index, efficiency index and volatility index. Total capital declined 13.7% from $9.29M to $8.02M.
Applied DNA Sciences, Inc. (APDN) was downgraded to E+ from D- on 8/11/2017 due to a decline in the total return index, efficiency index and volatility index. Total capital declined 13.7% from $9.29M to $8.02M.
D
Sell
11/18/2016Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D- from D on 11/18/2016 due to a decline in the volatility index.
Applied DNA Sciences Inc. (APDN) was downgraded to D- from D on 11/18/2016 due to a decline in the volatility index.
D
Sell
9/19/2016Upgraded
Applied DNA Sciences Inc. (APDN) was upgraded to D from D- on 9/19/2016 due to an increase in the volatility index.
Applied DNA Sciences Inc. (APDN) was upgraded to D from D- on 9/19/2016 due to an increase in the volatility index.
D
Sell
8/12/2016Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D- from D on 8/12/2016 due to a significant decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 5.52 to 3.92, and total capital declined 18.91% from $15.03M to $12.19M.
Applied DNA Sciences Inc. (APDN) was downgraded to D- from D on 8/12/2016 due to a significant decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 5.52 to 3.92, and total capital declined 18.91% from $15.03M to $12.19M.
D
Sell
3/11/2016Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D from D+ on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
Applied DNA Sciences Inc. (APDN) was downgraded to D from D+ on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
D
Sell
3/2/2016Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 3/2/2016 due to a decline in the total return index.
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 3/2/2016 due to a decline in the total return index.
C
Hold
2/16/2016Upgraded
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 2/16/2016 due to a significant increase in the efficiency index, solvency index and total return index. Net income increased 489.98% from -$496 to -$2.93M, the quick ratio increased from 4.22 to 7.52, and total capital increased 43.2% from $12.57M to $18M.
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 2/16/2016 due to a significant increase in the efficiency index, solvency index and total return index. Net income increased 489.98% from -$496 to -$2.93M, the quick ratio increased from 4.22 to 7.52, and total capital increased 43.2% from $12.57M to $18M.
D
Sell
5/11/2015Upgraded
Applied DNA Sciences Inc. (APDN) was upgraded to D+ from D on 5/11/2015 due to a major increase in the growth index and total return index. Total revenue increased 22.31% from $1.24M to $1.52M.
Applied DNA Sciences Inc. (APDN) was upgraded to D+ from D on 5/11/2015 due to a major increase in the growth index and total return index. Total revenue increased 22.31% from $1.24M to $1.52M.
D
Sell
2/18/2015Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D from D+ on 2/18/2015 due to a noticeable decline in the volatility index and total return index.
Applied DNA Sciences Inc. (APDN) was downgraded to D from D+ on 2/18/2015 due to a noticeable decline in the volatility index and total return index.
D
Sell
2/10/2015Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 2/10/2015 due to a decline in the valuation index and total return index.
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 2/10/2015 due to a decline in the valuation index and total return index.
C
Hold
2/2/2015Upgraded
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 2/2/2015 due to an increase in the volatility index.
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 2/2/2015 due to an increase in the volatility index.
D
Sell
1/15/2015Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 1/15/2015 due to a large decline in the volatility index and total return index.
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 1/15/2015 due to a large decline in the volatility index and total return index.
C
Hold
12/16/2014Upgraded
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 12/16/2014 due to a major increase in the volatility index and valuation index.
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 12/16/2014 due to a major increase in the volatility index and valuation index.
D
Sell
8/12/2014Downgrade
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 8/12/2014 due to a substantial decline in the volatility index, efficiency index and valuation index. Total capital declined 197.19% from -$320.2 to $311.2, and net income declined 30.22% from -$2.75M to -$1.92M.
Applied DNA Sciences Inc. (APDN) was downgraded to D+ from C- on 8/12/2014 due to a substantial decline in the volatility index, efficiency index and valuation index. Total capital declined 197.19% from -$320.2 to $311.2, and net income declined 30.22% from -$2.75M to -$1.92M.
C
Hold
5/14/2014Upgraded
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 5/14/2014 due to a large increase in the growth index, efficiency index and valuation index. Total revenue increased 6.65% from $597.4 to $637.1, and operating cash flow increased 6.28% from -$2.07M to -$2.2M.
Applied DNA Sciences Inc. (APDN) was upgraded to C- from D+ on 5/14/2014 due to a large increase in the growth index, efficiency index and valuation index. Total revenue increased 6.65% from $597.4 to $637.1, and operating cash flow increased 6.28% from -$2.07M to -$2.2M.
NASDAQ
05/03/2024 4:00PM Eastern
Quotes delayed
